A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine on Renal and Vascular Function in Subjects With Existing Hypertension Requiring Antihypertensive Therapy

Trial Profile

A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine on Renal and Vascular Function in Subjects With Existing Hypertension Requiring Antihypertensive Therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Oct 2017

At a glance

  • Drugs Amlodipine (Primary) ; Celecoxib (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Kitov Pharmaceuticals
  • Most Recent Events

    • 26 Oct 2017 According to a Kitov Pharmaceuticals media release, primary endpoint has been met. (Mean reduction in average daytime (9:00 to 21:00) ambulatory systolic blood pressure (SBPday))
    • 26 Oct 2017 Results published in a Kitov Pharmaceuticals Media Release.
    • 31 Jul 2017 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top